Abbott Laboratories (Brazil) Profile

BRL 0.09  0.15%

Abbott Laboratories Summary

Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in 100 Abbott Park Road and employs 99,000 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 419.64 B. Abbott Laboratories operates under Healthcare sector and is part of Medical Appliances and Equipment industry. This company has 1.74 B outstanding shares. ABBOTT -DRN has accumulated about 4.04 B in cash with 6.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31.
Check Abbott Laboratories Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 62.04HorizonTargetOdds Above 62.04
94.95%30 days 62.04 4.91%
Based on normal probability distribution, the odds of Abbott Laboratories to move above current price in 30 days from now is nearly 4.91% (This Abbott Laboratories probability density function shows the probability of Abbott Laboratories Stock to fall within a particular range of prices over 30 days) .

Abbott Laboratories Risk Profiles

Key Fundamentals

Abbott Laboratories Against Markets

Current Ratings

Abbott Laboratories 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Abbott Laboratories are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in Brazil and traded on Sao Paolo Stock Exchange. It employs 99000 people. more
NameAbbott Laboratories
ChairmanMiles WhiteView All
Macroaxis Advice
InstrumentBrazil Stock View All
Business Address100 Abbott Park Road
ExchangeSao Paolo Stock Exchange
IndustryMedical Appliances and Equipment
Phone224 667 6100
CurrencyBRL - Brazilian Real

Did you try this?

Run Equity Analysis Now

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Equity Analysis

Abbott Laboratories Corporate Directors

Samuel Scott Independent Director
Nancy McKinstry Independent Director
James Farrell Independent Director
Check also Trending Equities. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.